Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannect Group is a UK-based healthcare company dedicated to the advancement and distribution of medical cannabis. The company operates a vertically integrated model that includes specialist importation, distribution, and clinical education services aimed at the UK and European markets. Through its core brand, Cannect Healthcare, the group facilitates patient access to cannabinoid-based medicinal products (CBMPs) by providing a digital platform for clinicians and a reliable supply chain. Cannect also emphasizes the importance of clinical evidence and practitioner training through its Cannect Education arm. The company's mission is to normalize the use of medical cannabis within traditional healthcare systems for indications such as chronic pain and neurological disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannect Group.